The mercurial and Twitter-obsessed Tesla ($TSLA) CEO changed his handle overnight to "Elon Tusk" with an elephant emoji, and tweeted that there would be "some Tesla news" coming at 2 p.m. on Thursday.
A master of capturing media attention, Musk could be teasing a gimmicky Tesla feature, à la "Dog Mode," that would deflect some of the scrutiny he is once again under for tangling with the SEC over its regulatory practices. Or he could make a more serious announcement related to Model 3 production targets, or even how the company plans to pay off a $920 million convertible bond due on the first of the month.
The point is: no one knows ー and that's the problem. Earlier this week the SEC complained that Musk should be held in contempt for continuing to tweet market-moving investor information without prior sign-off from Tesla lawyers, which was part of Musk's settlement agreement with the agency.
That became infinitely more difficult when the company's general counsel quit last week after just two months.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
